New publications:

Aneta’s work was published in Journal of Neurochemistry providing the cover image.

Debarpan published his data on Developmental effect of RASopathy-linked PTPN11 mutation on synaptic vesicle fusion competence in Cellular and Molecular Neurobiology. Read the full text here.

Fewer synaptic vesicles fuse in response to electrical stimulation in cortical neurons expressing a PTPN11D61Y RASopathy mutation.

Congratulations and thank you and all the team for your efforts!

EURAS – EUropean network for neurodevelopmental RASopathies

We are proud to announce that EURAS project was funded in frame of European Union’s “Horizon Europe” research and innovation programme.

EURAS connects 16 partners form 8 European countries that will join forces to develop new effective therapies and operative disease management for neurodevelopmental RASopathies.

Read more

EURAS is coordinated form our institution and funded under grant agreement
No. 101080580.

New paper online:

We are pleased to announce a release of nice study led by our collaborator Prof. Christian Müller. It was pleasure to contribute, thanks Christian!

Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects

Neutral sphingomyelinase (NSM) and its coding gene SMPD3 is a single source for multiple pathways interlinking alcohol abuse—depression/anxiety—bone disorder (DH dorsal hippocampus, Nac nucleus accumbens).